65 results
424B3
EVOK
Evoke Pharma Inc
14 Mar 24
Prospectus supplement
6:44pm
its pre-change net operating loss carryforwards and other pre-change tax attributes to offset its post-change income may be limited. As a result … not changed, tax losses generated in calendar year 2018 and beyond do not expire, but may only offset 80% of our taxable income. This change may require us
424B4
EVOK
Evoke Pharma Inc
9 Feb 24
Prospectus supplement with pricing info
5:14pm
may be offset by certain U.S.-source capital losses of the non-U.S. holder (even though the individual is not considered a resident of the United